Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q1	2.798B / --	--
Jan 30, 2024	2024/Q3	2.675B / --	--
Jul 30, 2024	2024/Q1	2.922B / --	--
Jan 30, 2023	2023/Q3	2.824B / --	--
Jul 28, 2022	2023/Q1	2.444B / --	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q12.798B / ----

Jan 30, 20242024/Q32.675B / ----

Jul 30, 20242024/Q12.922B / ----

Jan 30, 20232023/Q32.824B / ----

Jul 28, 20222023/Q12.444B / ----

Unlock Free Earnings Estimates

Open Account

Hirose Tusyo Earnings Reports

Hirose Tusyo: Extraordinary Report

Dec 15, 2024 19:51 ET

Hirose Tusyo: Confirmation letter

Nov 14, 2024 02:14 ET

Hirose Tusyo: Interim report - 22nd term (2024/04/01 - 2025/03/31)

Nov 14, 2024 02:13 ET

Hirose Tusyo: Summary of financial results for the 2nd quarter (interim period) for the fiscal year ending March 31, 2025 [Japanese GAAP] (Consolidated)

Oct 30, 2024 03:30 ET

Symbol Price % Chg

D. Western Therapeutics Institute

4576

201 +23.31%

See the daily top gainer.